在结核性硬化综合体中,TFEB驱动mTORC1过度激活和脏疾病
Nicola Alesi1, Damir Khabibullin2, Dean M Rosenthal2
1Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. nalesi@bwh.harvard.edu.
Nature communications
|January 9, 2024
概括
结核性硬化综合体 (TSC) 病是由转录因子TFEB驱动的. 淘汰TFEB在TSC小鼠模型中拯救了病理和生存,这表明TFEB是治疗目标.
科学领域:
- 细胞生物学 细胞生物学
- 遗传学 遗传学 是一个
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 结核性硬化综合体 (TSC) 由TSC1/TSC2突变产生的,导致mTORC1过度活化和器官损伤.
- TFEB在TSC中具有构成性活性,这表明它在疾病发病过程中发挥了作用.
研究的目的:
- 研究TFEB在TSC相关病理中的作用.
- 探索TFEB作为TSC脏病的治疗标.
主要方法:
- 产生了两个小鼠模型的TSC与初级病理.
- 利用TFEB淘汰赛来评估其对TSC脏病的影响.
- 检查了mTORC1活性,TFEB局部化和溶酶体基因表达.
主要成果:
- 在TSC小鼠模型中,TFEB淘汰赛挽救了病理,改善了TSC小鼠的生存率.
- 在TSC2缺陷脏中,TFEB淘汰赛使mTORC1活性增加正常化.
- 在TSC模型中,Rapamycin治疗的益处是TFEB依赖的,正常化了溶酶体基因表达.
结论:
- TFEB是结核硬化综合体中病的主要驱动因素.
- 针对TFEB可能为TSC脏病提供一种新的治疗策略.
- 拉巴胺在TSC中的治疗作用通过TFEB依赖的途径进行介导.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Electron Transport Chain: Complex I and II
13.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.4K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


